河津正人

カワヅマサヒト | Kawazu Masahito

所属機関・部署：
職名：ユニット長

研究分野 (1件)：腫瘍生物学

論文 (53件)：

Akihito Kawazoe, Yasutoshi Kuboki, Eiji Shinozaki, Hiroki Hara, Tomohiro Nishina, Yoshito Komatsu, Satoshi Yuki, Masashi Wakabayashi, Shogo Nomura, Akihiro Sato, et al. Multicenter phase 1/2 Trial of napabucasin and pembrolizumab in patients with metastatic colorectal cancer (EPOC1503/SCOOP Trial). Clinical cancer research : an official journal of the American Association for Cancer Research. 2020. clincanres.1803.2020-clincanres.1803.2020
Shinichi Namba, Toshihide Ueno, Shinya Kojima, Yosuke Tanaka, Satoshi Inoue, Fumishi Kishigami, Noriko Maeda, Tomoko Ogawa, Shoichi Hazama, Yuichi Shiraishi, et al. Multi-sample Full-length Transcriptome Analysis of 22 Breast Cancer Clinical Specimens with Long-Read Sequencing. bioRxiv. 2020
Shogo Kumagai, Yosuke Togashi, Chika Sakai, Akihito Kawazoe, Masahito Kawazu, Toshihide Ueno, Eiichi Sato, Takeshi Kuwata, Takahiro Kinoshita, Masami Yamamoto, et al. An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells. Immunity. 2020. 53. 1. 187-203
Shinobu Tsuzuki, Takahiko Yasuda, Shinya Kojima, Masahito Kawazu, Koshi Akahane, Takeshi Inukai, Masue Imaizumi, Takanobu Morishita, Koichi Miyamura, Toshihide Ueno, et al. Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia. Blood Cancer Discovery. 2020. 1. 1. 82-95
Koshi Akahane, Takahiko Yasuda, Shinobu Tsuzuki, Fumihiko Hayakawa, Nobutaka Kiyokawa, Shinpei Somazu, Atsushi Watanabe, Keiko Kagami, Masako Abe, Daisuke Harama, et al. High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell lines. Hematological oncology. 2020

MISC (14件)：

特許 (4件)：

悪性リンパ腫又は白血病の罹患の有無の判別方法並びに白血病の治療及び/又は予防のための薬剤
RAC変異体を含む組成物、及びその使用方法
大腸癌検出用マーカー
MLH1メチル化群判定用マーカー及び判定方法

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

河津 正人

河津正人